HARDY REGINALD L 4
4 · Brickell Biotech, Inc. · Filed Sep 17, 2020
Insider Transaction Report
Form 4
HARDY REGINALD L
DirectorChairman of the Board
Transactions
- Award
Stock Option (right to buy)
2020-09-15+60,000→ 60,000 totalExercise: $0.80Exp: 2030-09-15→ Common Stock (60,000 underlying) - Award
Common Stock
2020-09-15$0.81/sh+15,226$12,333→ 205,849 total
Holdings
- 21,826(indirect: By Spouse)
Common Stock
- 9,261(indirect: By Spouse)
Common Stock
- 266,447(indirect: By Self as General Partner)
Common Stock
- 17,260(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]On September 15, 2020, the reporting person was granted 15,226 restricted stock units ("RSUs") in lieu of a portion of cash compensation as a director of Brickell Biotech, Inc. The RSUs are scheduled to vest on December 31, 2020 and will be settled in the form of one share of common stock for each RSU.
- [F2]The stock options will vest 25% on September 15, 2021, and the remainder will vest in equal monthly installments over the following three years.